Lamifen 250 mg 14 tablets
Composition:
Active Ingredient: Terbinafine 250 mg per tablet.
Excipients:
Oxypropylcellulose, hypromellose, microcrystalline cellulose, silicon dioxide, calcium stearate.
Product Description:
- Lamifen is a systemic antifungal medication with a broad spectrum of activity.
- It works by inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane, leading to the destruction of fungal cells.
- It is highly effective against dermatophytes (such as trichophyton, microsporum, and epidermophyton species), molds, and certain yeasts (including Candida species).
- When taken orally, it is not effective for treating pityriasis versicolor.
Indications for Use:
- Fungal infections of the scalp (tinea capitis).
- Fungal infections of the skin and nails (onychomycosis) caused by dermatophytes and molds.
- Severe or widespread fungal infections of the body and extremities requiring oral therapy.
- Cutaneous and mucosal candidiasis.
Method of Administration and Dosage:
- Administered orally with a glass of water.
- Adults: 1 tablet (250 mg) once daily.
- Treatment duration: Typically ranges from 2 to 6 weeks depending on the location and severity of the infection.
- Treatment for nail infections (onychomycosis) may require longer courses.
Contraindications:
- Acute or chronic liver diseases.
- Children under 2 years of age.
- Breastfeeding (lactation) period.
- Known hypersensitivity or allergic reactions to terbinafine or any of the excipients.
Precautions:
- Use with caution in patients with impaired kidney function, alcoholism, bone marrow depression, metabolic disorders, or vascular diseases.
- Regular administration is important; stopping treatment prematurely increases the risk of infection recurrence.
- If no improvement is observed after 2 weeks of skin infection treatment, consult a doctor for further evaluation.
- Visible clearing of nail infections occurs gradually as the healthy nail grows back (nail removal is not required during treatment).
- Periodic liver function monitoring may be recommended during prolonged treatment.
Adverse Reactions / Side Effects:
- Nervous System: Common: headache, dizziness.
- Skin and Allergic Reactions: Common: skin rash, hives; Rare: angioedema, hair loss; Very rare: severe skin reactions or psoriasis flare-ups.
- Musculoskeletal System: Common: joint pain (arthralgia) and muscle pain (myalgia).
- Hematopoietic System: Very rare: reversible decrease in white blood cell or platelet counts.
- General: Fatigue.
Pregnancy and Lactation:
Use during pregnancy is recommended only if the potential benefit to the mother outweighs the potential risk to the fetus.
Breastfeeding must be discontinued if treatment is required during lactation.
Storage Conditions:
Store at a temperature not exceeding 30 °C in a dry place protected from light.
Keep out of reach of children.
Packaging:
Cardboard box containing 2 blisters of 7 tablets each (total of 14 tablets) and a patient information leaflet.